Improving care of hospitalized patients with HIV in Tanzania

Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost.

Deciphering the male breast cancer genome

Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators.

Cornell launches new general counsel executive education program

Cornell Law School and Cornell Tech will host the General Counsel Summit, an executive education program for senior in-house attorneys and corporate leaders, on June 20 and 21, 2024, at Cornell Tech.

Around Cornell

Cornell Tech’s Pierson named Schmidt AI2050 fellow

Emma Pierson, assistant professor of computer science at the Jacobs Technion-Cornell Institute at Cornell Tech, has been awarded an AI2050 Early Career Fellowship from Schmidt Sciences for her work seeking to use AI to promote equity.

Digital campus guide makes Cornell Tech more accessible

Cornell Tech has launched a new digital guide highlighting the many cultural attributes of its campus on Bloomberg Connects, the free arts and cultural app created by Bloomberg Philanthropies.

Six early-career professors win NSF development awards

Researchers studying large-scale artificial intelligence, microbial biomanufacturing and causal inference methods are among the Cornell researchers who recently received National Science Foundation Faculty Early Career Development Awards.

Genetic signature may predict lung cancer response to immunotherapy

A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.

New insight into old IBD drug could improve treatments

Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.